Tracking and Therapeutic Value of Human Adipose Tissue–derived Mesenchymal Stem Cell Transplantation in Reducing Venous Neointimal Hyperplasia Associated with Arteriovenous Fistula
Author(s) -
Binxia Yang,
Akshaar Brahmbhatt,
Evelyn Nieves Torres,
Brian V. Thielen,
Deborah McCall,
Sean Engel,
Aditya Bansal,
Mukesh K. Pandey,
Allan B. Dietz,
Edward B. Leof,
Timothy R. DeGrado,
Debabrata Mukhopadhyay,
Sanjay Misra
Publication year - 2015
Publication title -
radiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.118
H-Index - 295
eISSN - 1527-1315
pISSN - 0033-8419
DOI - 10.1148/radiol.2015150947
Subject(s) - medicine , mesenchymal stem cell , neointimal hyperplasia , transplantation , adipose tissue , intimal hyperplasia , vein , pathology , adventitia , real time polymerase chain reaction , hyperplasia , urology , surgery , stent , restenosis , smooth muscle , biochemistry , chemistry , gene
To determine if adventitial transplantation of human adipose tissue-derived mesenchymal stem cells (MSCs) to the outflow vein of B6.Cg-Foxn1(nu)/J mice with arteriovenous fistula (AVF) at the time of creation would reduce monocyte chemoattractant protein-1 (Mcp-1) gene expression and venous neointimal hyperplasia. The second aim was to track transplanted zirconium 89 ((89)Zr)-labeled MSCs serially with positron emission tomography (PET) for 21 days.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom